| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 704.84B | 699.37B | 672.45B | 642.95B | 612.66B | 656.74B |
| Gross Profit | 41.68B | 41.16B | 39.55B | 37.93B | 35.05B | 35.34B |
| EBITDA | 10.44B | 10.25B | 9.61B | 9.67B | 8.04B | 7.25B |
| Net Income | 8.75B | 8.21B | 6.60B | 4.84B | 4.32B | 4.03B |
Balance Sheet | ||||||
| Total Assets | 283.83B | 271.55B | 274.50B | 248.06B | 237.61B | 231.93B |
| Cash, Cash Equivalents and Short-Term Investments | 1.74B | 1.45B | 1.61B | 10.77B | 7.67B | 2.61B |
| Total Debt | 3.50B | 4.20B | 4.11B | 4.69B | 5.78B | 5.97B |
| Total Liabilities | 165.21B | 155.96B | 165.23B | 148.28B | 142.37B | 138.59B |
| Stockholders Equity | 118.60B | 115.57B | 109.25B | 99.76B | 95.22B | 93.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.05B | 10.15B | 7.38B | 4.38B | 7.83B |
| Operating Cash Flow | 0.00 | -3.73B | 10.53B | 7.68B | 5.24B | 8.01B |
| Investing Cash Flow | 0.00 | 503.00M | -1.66B | -2.42B | 1.63B | -14.53B |
| Financing Cash Flow | 0.00 | -2.04B | -1.72B | -2.16B | -1.78B | -1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥30.93B | 9.72 | ― | 1.94% | 3.15% | 27.71% | |
69 Neutral | ¥164.55B | 9.61 | ― | 1.39% | 3.91% | -0.28% | |
68 Neutral | ¥16.74B | 2.44 | ― | 3.17% | 5.19% | 11.04% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥135.78B | 14.71 | ― | 3.02% | 2.16% | -24.33% | |
61 Neutral | ¥48.84B | 3.77 | ― | 0.52% | 20.97% | -56.39% | |
58 Neutral | ¥72.12B | 15.39 | ― | 1.48% | 8.41% | -3.65% |